ArticleTechnology in cancer research & treatment

Combining Immunotherapy with Anlotinib in Extensive-Stage Small Cell Lung Cancer: A Multicenter Analysis of Efficacy and Safety.

Guogang Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.